DERMATOLOGIC SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2021-12-28 MS68862005

讨论中局限性怎么撰写？

212 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2021-12-28 Mia

是否需要在讨论中说明文章局限性？

258 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2020-09-24 1e12becdm16(暂无匿称)

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：DFSP;surgery
经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版

288 0

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2020-07-17 ms1000000702618910

审稿速度:3.0 | 投稿命中率:25.0
经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿

302 0

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2020-02-20 1e12becdm16(暂无匿称)

目前5个月，发邮件还没回复

306 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2020-02-15 1e12becdm16(暂无匿称)

你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表:
杂志的文章不显示投稿日期和接受日期。搞不清楚快慢

Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢

292 0

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2020-02-12 1e12becdm16(暂无匿称)

审稿速度:3.0
经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。

311 0

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2020-01-21 Atropine1470

杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表:
18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收

133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收

309 0

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2019-11-12 ms9686134410729756

这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。

308 0

[GetPortalCommentsPageByObjectIdResponse(id=1089254, encodeId=93111089254d2, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089253, encodeId=78f51089253c7, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888082, encodeId=409b88808223, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：DFSP;surgery 经验分享：写的DFSP总体编辑比较友好，但是第一投3月后让大修，又过3个月小修。第2次修后回复比较快，总共历时9个月。大家加油。但是出版时间长。目前accept后5个月未出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Sep 24 22:07:35 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803143, encodeId=7560803143b6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：论著，3个月，拒稿。唉，如果拒稿，能不能快一点，三个月才拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dc55401186, createdName=ms1000000702618910, createdTime=Fri Jul 17 22:00:54 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585078, encodeId=fe955850e8df, content=目前5个月，发邮件还没回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Thu Feb 20 00:00:00 CST 2020, time=2020-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584767, encodeId=a4da584e679f, content=你怎么样了，我这都5个月了。Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, beContent=Atropine 2020-01-21 00:00:00 发表: 杂志的文章不显示投稿日期和接受日期。搞不清楚快慢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584618, encodeId=42d8584618ef, content=审稿速度:3.0 经验分享：2019年9月投，2019年11月催稿，催稿一周给了修改意见，只有一个审稿人，让改改摘要。目前2020你那2月12，仍然是underreview。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7c91957823, createdName=1e12becdm16(暂无匿称), createdTime=Wed Feb 12 14:26:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583682, encodeId=dd285836825c, content=杂志的文章不显示投稿日期和接受日期。搞不清楚快慢133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: 18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/21/2a6cd4676316630b9244051d6063f746.jpg, createdBy=1bfe5268327, createdName=Atropine1470, createdTime=Tue Jan 21 00:00:00 CST 2020, time=2020-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854922, encodeId=f0718549221a, content=这个杂志，编辑确实很友好。目前2月，我发了催稿信。之后1星期，回复让我修改。希望能中。加油。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6f95414014, createdName=ms9686134410729756, createdTime=Tue Nov 12 15:01:03 CST 2019, time=2019-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571704, encodeId=de645e170488, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=)]

2019-05-30 124a44c5m26暂无昵称

审稿速度:6.0 | 投稿命中率:50.0
经验分享：18.12.14投稿 19.02.01一审小修 19.02.16修回 19.04.07二审小修 19.04.13修回 19.05.26接收

285 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务